Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...

The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...

If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...

Spravato, okayed for stand-alone use among adults, is the first such therapy for major depressive disorder (MDD) that is ...

CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

One-third of folks with major depressive disorder experience treatment-resistant depression (TRD), a condition that makes it ...

A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.

While studies have associated Morganella morganii and major depressive disorder before, this study deciphers how they are ...

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

The U.S. Food and Drug Administration has approved a nasal spray that is known to help treat depression.